We generated a surface protein metric called surface TCR.strong based on the geometric mean of OX40 and ICOS MFI (Supplementary Fig. 2), the transcripts of which we have previously reported to be enriched in melanoma patient responders to Nivolumab [2]. This evidence concerns the gene ICOS and melanoma.